Site Search

... to helping others even at the end of her life. Six months later, Wilma passed away, but the procedure she underwent became the standard of care for her kind of cancer.  In 2003 Mary met Beth, whose life was saved from the belly wash, now known as a hot chemo bath. Beth is a daughter, ... that Wilma’s insurance covered the clinical trial and wants to see all Americans have access to clinical trials, regardless of the type of health insurance they have. “Clinical trials are hope. If you have exhausted traditional methods of treatment, why should anyone be able to steal ... We don’t know how the treatments being researched today are going to help the person of tomorrow.”    Read More Stories About Barriers to Care     Wilma: New Albany, IN ...

... and partners are working together to make sure more Kentuckians can benefit from this important testing.   What is Biomarker Testing? In cancer care, biomarkers are often used to help determine the best treatment for a patient . A “ biomarker ” is a sign of a normal biological process, ... that have been excluded, including communities of color, individuals with lower socioeconomic status, rural communities, and those receiving care in non-academic medical centers, are less likely to receive biomarker testing. Improving coverage for and access to biomarker testing across insurance types is key to reducing health disparities. Without action to expand coverage and access to biomarker testing, advances in precision medicine could increase existing ...

...   “Today, Michigan took an important first step to easing the burden of cancer and ensuring costs will not be a barrier to effective care. We’d like to thank the Senate, especially bill sponsor State Senator Goeff Hansen, for standing up for cancer patients.   “When offered ... some types of cancer are only treatable through oral medications, meaning that price tag can keep many patients from even accessing effective care. That’s a matter of life or death.   “Michigan has the opportunity to join most other states that have put these protections in place. We ... ACS CAN is the nonprofit, nonpartisan advocacy affiliate organization of the American Cancer Society, dedicated to eliminating cancer as a major health problem. ACS CAN works to encourage lawmakers, candidates and government officials to support laws and policies that will make cancer a top ...

... their story about access to biomarker testing. Video of additional_patient_stories_biomarkers   What is Biomarker Testing? In cancer care, biomarkers are often used to help determine the best treatment for a patient . A “ biomarker ” is a sign of a normal biological process, ... that have been excluded, including communities of color, individuals with lower socioeconomic status, rural communities, and those receiving care in non-academic medical centers are less likely to receive biomarker testing. Improving coverage for and access to biomarker testing across insurance types is key to reducing health disparities. Without action to expand coverage and access to biomarker testing, advances in precision medicine could increase existing ...